Zobrazeno 1 - 6
of 6
pro vyhledávání: '"L V, Chesnokova"'
Autor:
L. V. Chesnokova
Publikováno v:
Philosophical Problems of IT & Cyberspace (PhilIT&C). :22-38
The article examines the situation associated with the spread of social networks, which brought not only new communication opportunities, but also the risks of blurring the boundaries between privacy and publicity. People voluntarily share personal d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac39268ea73b514c25d08d6ff9f42e69
https://doi.org/10.17726/philit.2021.2.2
https://doi.org/10.17726/philit.2021.2.2
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 25, Iss 1, Pp 66-73 (2015)
Aim of investigation. To study the effect of nonpharmaceutical correction of body weight on the level ofhigh cardio-vascular risk markers at non-alcoholic fatty liver disease (NAFLD).Material and methods. Overall 117 patients with NAFLD at steatosis
Externí odkaz:
https://doaj.org/article/72ab086ab10c42438d611b331eaaed38
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 24, Iss 6, Pp 45-50 (2014)
Aim of investigation. Complex estimation of endothelial function at non-alcoholic fatty liver disease (NAFLD) in association with early disorders of carbohydrate metabolism, in relation to liver fibrosis severity.Material and methods. Overall 67 pati
Externí odkaz:
https://doaj.org/article/18ff784d39884b1fae69c247556e813f
Autor:
L. V. Chesnokova
Publikováno v:
Gumanitarnye vedomosti TGPU im. L.N. Tolstogo. :39-50
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::febc8c6d0a85c183be2a0d8c0f6f8648
https://doi.org/10.22405/2304-4772-2021-1-2-39-50
https://doi.org/10.22405/2304-4772-2021-1-2-39-50
Publikováno v:
Ожирение и метаболизм, Vol 11, Iss 2, Pp 17-23 (2014)
The increased interest in non-alcohol liver disease research is due to the increased incidence of obesity in developed countries. Thus liver disease is prevalent in 20-40 % of population. Nevertheless fibrosis is found not in every patient, which mak
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6aae0c239795afa8f7002a589697cab6
https://www.omet-endojournals.ru/jour/article/view/6718
https://www.omet-endojournals.ru/jour/article/view/6718
Publikováno v:
Klinicheskaia meditsina. 91(12)
To study levels of systemic inflammation markers and plasminogen activator inhibitor-1 (PAL-1) in patients with metabolic syndrome (MS) and establish their relationship with the progress of selected stages of non-alcoholic fatty liver disease (NAFLD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::93a42d64a1e4cd9f7871b4c0f4b86f81
https://pubmed.ncbi.nlm.nih.gov/25702427
https://pubmed.ncbi.nlm.nih.gov/25702427